22 participants
A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-08-25
- Start Date:
- 2023-11-15
- Completion:
- 2025-11-14
Conditions
- Recurrent Glioblastoma
Interventions
- DRUG
No Results Yet